Patent details

EP1924250 Title: METHODS AND COMPOSITIONS COMPRISING IMMUNOMODULATORY COMPOUNDS FOR USE FOR THE TREATMENT OF IMMUNODEFICIENCY DISORDERS

Basic Information

Publication number:
EP1924250
PCT Application Number:
PCT/US/2005/043360
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP058525551
PCT Publication Number:
WO/2006/060507
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
METHODS AND COMPOSITIONS COMPRISING IMMUNOMODULATORY COMPOUNDS FOR USE FOR THE TREATMENT OF IMMUNODEFICIENCY DISORDERS
French Title of Invention:
PROCÉDÉS ET COMPOSITIONS COMPRENANT DES AGENTS IMMUNOMODULATEURS POUR UTILISATION DANS LE TRAITEMENT DE MALADIES IMMUNODÉFICITAIRES
German Title of Invention:
VERFAHREN UND ZUSAMMENSETZUNGEN MIT IMMUNMODULIERENDEN VERBINDUNGEN ZUR VERWENDUNG ZUR BEHANDLUNG VON IMMUNDEFEKTSTÖRUNGEN
SPC Number:

Dates

Filing date:
30/11/2005
Grant date:
04/01/2017
EP Publication Date:
04/01/2017
PCT Publication Date:
08/06/2006
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
28/05/2008
EP B1 Publication Date:
04/01/2017
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
30/11/2017
Expiration date:
30/11/2025
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
30/11/2005
 
 

Name:
CELGENE CORPORATION
Address:
86 Morris Avenue, Summit, NJ 07901, United States (US)

Inventor

1

Name:
CORRAL Laura, G.
Address:
United States (US)

2

Name:
XU Weiming
Address:
United States (US)

Priority

Priority Number:
631870 P
Priority Date:
01/12/2004
Priority Country:
United States (US)

Classification

Main IPC Class:
A61K 31/00;

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages